Other links concerning Notifiable Conditions

• Local Health Jurisdictions

• How to Report a Notifiable Condition

• Reporting Forms

• Guidelines

• Disease Surveillance Data

• Glossary

• Legal Requirements

• EpiTrends

• Notifiable Conditions & the Health Care Provider (PDF, 645KB)

• Notifiable Conditions & the Hospital  (PDF, 529KB)

• Notifiable Conditions & the Laboratory  (PDF, 314KB)

• Notifiable Conditions & the Local Health Jurisdiction  (PDF, 117KB)

• Notifiable Conditions & the Veterinarian (PDF, 129KB)

• Communicable Disease Epidemiology

• WEDSS (Washington Electronic Disease Surveillance System)

PDF documents require the free Acrobat Reader. Click here to download a copy.

Reporting Adverse Events from Smallpox (Vaccinia) Vaccine

Adverse events specifically related to smallpox (vaccinia) vaccination include:

• inadvertent inoculation

• generalized vaccinia

• eczema vaccinatum

• progressive vaccinia

• post-vaccinial encephalitis

• fetal vaccinia, and

• bacterial infections of the vaccination site.

Acute allergic reactions (anaphylaxis) and erythema multiforme may also occur.

Unlike other vaccines, an adverse event may occur not only in the person vaccinated (vaccinee), but among their close contacts as well (secondary vaccinia). 

Serious adverse events (life-threatening or requiring CDC consultation or investigational drug treatment) should be reported immediately by telephone to the DOH Communicable Disease Epidemiology 24-hour telephone hotline at 206-418-5500 or toll-free at 1-877-593-4344, unless instructed otherwise by your local health department.

A clinician will be available for consultation, and instructions on completing and submitting a Vaccine Adverse Events Reporting System (VAERS) form will be given at that time. VAERS forms should be faxed within 24 hours to the DOH Communicable Disease Epidemiology confidential fax line at 206-361-2930.

Other adverse events should be reported by telephone or fax within 48 hours to your local health department or DOH Communicable Disease Epidemiology at the telephone or fax numbers above.

Last guideline update
Feb. 2003